✦ LIBER ✦

EORTC Early Clinical Studies Group early phase II trial of S-1 in patients with advanced or metastatic colorectal cancer

✍ Scribed by Van den Brande, J; Schöffski, P; Schellens, J H M; Roth, A D; Duffaud, F; Weigang-Köhler, K; Reinke, F; Wanders, J; de Boer, R F; Vermorken, J B

Book ID: 109997492
Publisher: Nature Publishing Group
Year: 2003
Tongue: English
Weight: 117 KB
Volume: 88
Category: Article
ISSN: 0007-0920
DOI: 10.1038/sj.bjc.6600781

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Docetaxel (TaxotereTM) in advanced gastr

Docetaxel (TaxotereTM) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

✍ Sulkes, A; Smyth, J; Sessa, C; Dirix, LY; Vermorken, JB; Kaye, S; Wanders, J; Fr 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 745 KB

Phase II trial of S-1 in combination wit

Phase II trial of S-1 in combination with gemcitabine for chemo-naïve patients with locally advanced or metastatic pancreatic cancer

✍ Gyeong-Won Lee; Hye Jung Kim; Ji-Hyun Ju; Seok-Hyun Kim; Hoon Gu Kim; Tae Hyo Ki 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 305 KB

Carzelesin phase II study in advanced br

Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG)

✍ Nicholas Pavlidis; Steinar Aamdal; Ahmad Awada; Hilary Calvert; Pierre Fumoleau; 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 80 KB

Phase II study of flutamide in patients

Phase II study of flutamide in patients with metastatic breast cancer. A National Cancer Institute of Canada Clinical Trials Group study

✍ Daniele J. Perrault; Diane M. Logan; David J. Stewart; Vivien H. C. Bramwell; Al 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 271 KB

The National Cancer Institute of Canada (NCIC) Clinical Trials Group conducted a phase II study of the oral antiandrogen flutamide in 33 patients with metastatic breast cancer. Eight patients had received no prior systemic therapy for their metastatic disease and 13 had only one site of metastasis.

An early phase II trial of S-1 in Japane

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

✍ Seiji Naito; Taiji Tsukamoto; Michiyuki Usami; Hiroyuki Fujimoto; Hideyuki Akaza 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 292 KB

A phase II study of S-1 in patients with

A phase II study of S-1 in patients with metastatic breast cancer — A Japanese trial by the S-1 cooperative study group, breast cancer working group

✍ Toshiaki Saeki; Shigemitsu Takashima; Muneaki Sano; Noboru Horikoshi; Shigeto Mi 📂 Article 📅 2004 🏛 Springer Japan 🌐 English ⚖ 990 KB